Photo: ruizluquepaz/Getty Images
GE HealthCare is expanding its collaboration with DeepHealth to broaden customer access to Breast Suite's AI-powered mammography applications.
The expanded partnership makes additional Breast Suite capabilities available, including ProFound Pro – which combines clinical AI Cancer Detection and an Automated Density Assessment – and a second reader workflow called Safeguard Review, as well as a cloud-based multi-modality viewer.
A U.S. study has found that the use of Safeguard Review has demonstrated a 21% increase in breast cancer detection rates and a 23% increase for women with dense breasts, according to GE HealthCare.
The companies' wider suite of AI tools is aimed at enhancing breast cancer care and extending these offerings to new regions outside the United States.
The announcement builds on the companies' prior joint initiatives and coincides with the Society of Breast Imaging Annual Symposium this past week in Seattle, where GE HealthCare showcased the combined offerings.
The expanded collaboration builds on the joint initiative first announced in 2024, which united DeepHealth's AI-powered breast cancer screening workflow with GE HealthCare's Senographe Pristina mammography system to enhance image interpretation and improve operational efficiency.
DeepHealth, a subsidiary of RadNet, offers AI-powered health informatics. GE HealthCare is a $20.6 billion business.
"At GE HealthCare, we're advancing women's health through precision care built around the unique needs of women and enhanced by the power of AI," said Jyoti Gupta, president and CEO of Women's Health and X-ray at GE HealthCare. "By integrating Breast Suite AI with our Pristina Via mammography system, we're helping clinicians detect breast cancer early with greater confidence. These innovations move us closer towards truly personalized prevention and care for women."
Email the writer: SMorse@himss.org